CD274 and breast cancer: Programmed death ligand-1 (PD-L1) is a well-studied immune checkpoint inhibitor of programmed death 1 (PD-1), a T-cell negative regulator, and is upregulated on the surface of solid tumors, including breast cancers [2, 9].